Sen. Marshall Questions President Biden Officials After Emergency Room Visits Increase by 500% From Chemical Abortions
April 27, 2022
April 27, 2022
WASHINGTON, April 27 -- Sen. Roger Marshall, R-Kansas, issued the following news release on April 26, 2022:
U.S. Senator Roger Marshall, M.D. today questioned Food and Drug Administration (FDA) Director for the Center for Drug Evaluation and Research, Dr. Patrizia Cavazzoni, about the Biden Administration's efforts to reduce safety protocols for Chemical abortion drugs. The Senator said in part,
"Last week, we received a letter from Commissioner Califf on FDA& . . .
U.S. Senator Roger Marshall, M.D. today questioned Food and Drug Administration (FDA) Director for the Center for Drug Evaluation and Research, Dr. Patrizia Cavazzoni, about the Biden Administration's efforts to reduce safety protocols for Chemical abortion drugs. The Senator said in part,
"Last week, we received a letter from Commissioner Califf on FDA& . . .